文献
J-GLOBAL ID:202202285529579490
整理番号:22A0902088
自閉症のバルプロ酸ラットモデルにおけるペルオキシソーム増殖因子活性化受容体αの新規役割:リスペリドンとメトホルミン単独療法対併用の機構研究【JST・京大機械翻訳】
Novel role of peroxisome proliferator activated receptor-α in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination
著者 (8件):
Elnahas Esraa M.
(Clinical Pharmacology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt)
,
Abuelezz Sally A.
(Clinical Pharmacology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt)
,
Mohamad Magda I.
(Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt)
,
Nabil Mai M.
(Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt)
,
Abdelraouf Sahar M.
(Department of Biochemistry, Faculty of Pharmacy, Misr International University, Cairo, Egypt)
,
Bahaa Nevine
(Histology and Cell Biology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt)
,
Hassan Ghada A.M.
(Neuropsychiatry Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt)
,
Aboul-Fotouh Sawsan
(Clinical Pharmacology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt)
資料名:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
(Progress in Neuro-Psychopharmacology & Biological Psychiatry)
巻:
116
ページ:
Null
発行年:
2022年
JST資料番号:
T0252A
ISSN:
0278-5846
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)